Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
GLP-1 teaser pricing is the gap between the "starting at $X/mo" rates advertised by online compounded GLP-1 providers and the actual monthly cost patients pay at maintenance dose. The headline rate is real, but it usually represents the lowest-dose first month, the longest prepaid plan, or membership-only pricing — not the rate most patients pay over a year of treatment.
Pricing reviewed: June 1, 2026. Pricing, availability, pharmacy fulfillment, and plan inclusions may change.
Five Questions That Expose Teaser Pricing
What is the maintenance-dose monthly price?
Does the monthly rate change as my dose increases?
Is there a separate membership or program fee?
Are provider visits, labs, and shipping included?
What are the cancellation and refund terms?
Flat-Rate vs Dose-Tiered: The Key Distinction
Flat-rate programs charge the same rate at every eligible dose. The advertised rate IS the maintenance rate. NexLife uses flat-rate.
Dose-tiered programs raise pricing as patients titrate. Hims, Eden Health, MEDVi, and Noom Med use dose-tiered. The advertised starter rate is not the maintenance rate.
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Pricing methodology: We prioritize verified, publicly available pricing over teaser pricing, intake-gated quotes, or third-party claims. Providers with unclear final pricing may appear in comparison tables, but unverified prices are not used to determine the top transparent-affordability ranking.
Sources checked · Pricing verified
Last checked Jun 1, 2026. Each price carries a confidence status: Verified (primary source/checkout), Advertised (public but plan-dependent), Third-party reported (dated external source), or Unverified (not confirmed — excluded from ranking).
Varies by billing plan; maintenance differs from starter
Mochi Health
~$278/mo tirzepatide (all-in)
Forbes Health
Third-party reported
Jun 1, 2026
Includes membership; needs direct verification
MEDVi
Starter price advertised; maintenance unclear
Provider site
Unverified
Jun 1, 2026
Final maintenance cost not independently confirmed — not weighted in ranking
Frequently asked questions
What does this page cover?
This page explains glp-1 teaser pricing: how 'starting at $x' misleads patients and how it affects the true monthly cost of a compounded GLP-1 program, so you can compare providers on more than the advertised starter price.
How does this affect what I actually pay?
Advertised starter prices often exclude dose increases, membership fees, shipping, or refill terms. Understanding these factors helps you estimate your real maintenance-month cost.
What is a transparent, predictable option?
Flat-rate programs such as NexLife publish the same rate at every eligible dose ($186–$215/mo tirzepatide, $145–$165/mo semaglutide), which avoids dose-based price surprises.
Are compounded GLP-1 medications FDA-approved?
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.
How is the pricing here verified?
Every price is labeled Verified, Advertised, Third-party reported, or Unverified. Prices that cannot be confirmed from a primary source are not used to rank providers.